Cox S N, Pesce F, El-Sayed Moustafa J S, Sallustio F, Serino G, Kkoufou C, Giampetruzzi A, Ancona N, Falchi M, Schena F P
Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy.
C.A.R.S.O. Consortium, University of Bari, Bari, Italy.
J Intern Med. 2017 Feb;281(2):189-205. doi: 10.1111/joim.12565. Epub 2016 Oct 11.
IgA nephropathy (IgAN) is a common complex disease with a strong genetic involvement. We aimed to identify novel, rare, highly penetrant risk variants combining family-based linkage analysis with whole-exome sequencing (WES).
Linkage analysis of 16 kindreds of South Italian ancestry was performed using an 'affected-only' strategy. Eight most informative trios composed of two familial cases and an intrafamilial control were selected for WES. High-priority variants in linked regions were identified and validated using Sanger sequencing. Custom TaqMan assays were designed and carried out in the 16 kindreds and an independent cohort of 240 IgAN patients and 113 control subjects.
We found suggestive linkage signals in 12 loci. After sequential filtering and validation of WES data, we identified 24 private or extremely rare (MAF <0.0003) linked variants segregating with IgAN status. These were present within coding or regulatory regions of 23 genes that merged into a common functional network. The genes were interconnected by AKT, CTNNB1, NFKB, MYC and UBC, key modulators of WNT/β-catenin and PI3K/Akt pathways, which are implicated in IgAN pathogenesis. Overlaying publicly available expression data, genes/proteins with expression notably altered in IgAN were included in this immune-related network. In particular, the network included the glucocorticoid receptor gene, NR3C1, which is the target of corticosteroid therapy routinely used in the treatment of IgAN.
Our findings suggest that disease susceptibility could be influenced by multiple rare variants acting in a common network that could provide the starting point for the identification of potential drug targets for personalized therapy.
IgA肾病(IgAN)是一种常见的复杂疾病,有很强的遗传因素参与。我们旨在通过基于家系的连锁分析与全外显子测序(WES)相结合来鉴定新的、罕见的、高外显率的风险变异。
采用“仅患病人群”策略对16个意大利南部血统的家系进行连锁分析。选择由两个家族性病例和一个家族内对照组成的8个信息最丰富的三联体进行WES。使用Sanger测序鉴定并验证连锁区域中的高优先级变异。设计定制的TaqMan分析,并在16个家系以及240例IgAN患者和113例对照受试者的独立队列中进行。
我们在12个位点发现了提示性的连锁信号。在对WES数据进行连续筛选和验证后,我们鉴定出24个与IgAN状态共分离的私有或极其罕见(MAF<0.0003)的连锁变异。这些变异存在于23个基因的编码或调控区域内,这些基因合并成一个共同的功能网络。这些基因通过AKT、CTNNB1、NFKB、MYC和UBC相互连接,它们是WNT/β-连环蛋白和PI3K/Akt通路的关键调节因子,与IgAN发病机制有关。叠加公开可用的表达数据,在IgAN中表达明显改变的基因/蛋白质被纳入这个免疫相关网络。特别是,该网络包括糖皮质激素受体基因NR3C1,它是IgAN治疗中常规使用的皮质类固醇疗法的靶点。
我们的研究结果表明,疾病易感性可能受作用于共同网络的多个罕见变异的影响,这可能为鉴定个性化治疗的潜在药物靶点提供起点。